{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T02:27:04Z","timestamp":1787452024366,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,2]],"date-time":"2021-05-02T00:00:00Z","timestamp":1619913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013108","name":"Special Foundation for the Development of Strategic Emerging Industries of Shenzhen","doi-asserted-by":"publisher","award":["20180309163446298"],"award-info":[{"award-number":["20180309163446298"]}],"id":[{"id":"10.13039\/501100013108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903090"],"award-info":[{"award-number":["81903090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81922046"],"award-info":[{"award-number":["81922046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M672856"],"award-info":[{"award-number":["2020M672856"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009019","name":"Shenzhen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFA0105900"],"award-info":[{"award-number":["2017YFA0105900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bcp.2021.114588","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T21:01:37Z","timestamp":1620075697000},"page":"114588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Nitazoxanide impairs mitophagy flux through ROS-mediated mitophagy initiation and lysosomal dysfunction in bladder cancer"],"prefix":"10.1016","volume":"190","author":[{"given":"Haiyan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shupeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114588_b0005","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"19","key":"10.1016\/j.bcp.2021.114588_b0010","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: A Review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bcp.2021.114588_b0015","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer","volume":"71","author":"Alfred Witjes","year":"2017","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bcp.2021.114588_b0020","doi-asserted-by":"crossref","unstructured":"Bladder cancer: diagnosis and management of bladder cancer: (c) NICE (2015) Bladder cancer: diagnosis and management of bladder cancer. BJU Int 2017, 120(6):755-765.","DOI":"10.1111\/bju.14045"},{"key":"10.1016\/j.bcp.2021.114588_b0025","article-title":"Role of immunotherapy in bladder cancer","volume":"26","author":"Rhea","year":"2021","journal-title":"Cancer Treat Res Commun"},{"issue":"10109","key":"10.1016\/j.bcp.2021.114588_b0030","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/S0140-6736(17)32365-6","article-title":"Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): A randomised, double-blind, phase 3 trial","volume":"390","author":"Petrylak","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.bcp.2021.114588_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113461","article-title":"Challenges and therapeutic opportunities of autophagy in cancer therapy","volume":"12","author":"Silva","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"22","key":"10.1016\/j.bcp.2021.114588_b0040","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1101\/gad.1599207","article-title":"Autophagy: process and function","volume":"21","author":"Mizushima","year":"2007","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.bcp.2021.114588_b0045","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019101812","article-title":"Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4","volume":"38","author":"Scherz-Shouval","year":"2019","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.bcp.2021.114588_b0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114588_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050761","article-title":"High Levels of ROS impair lysosomal acidity and autophagy flux in glucose-deprived fibroblasts by activating ATM and Erk Pathways","volume":"10","author":"Song","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2021.114588_b0060","first-page":"99","article-title":"Autophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence","author":"Tai","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.bcp.2021.114588_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101751","article-title":"Diclofenac impairs autophagic flux via oxidative stress and lysosomal dysfunction: Implications for hepatotoxicity","volume":"37","author":"Jung","year":"2020","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114588_b0070","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10571-015-0166-x","article-title":"ROS and Autophagy: Interactions and molecular regulatory mechanisms","volume":"35","author":"Li","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.bcp.2021.114588_b0075","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.120080","article-title":"PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65","volume":"2","author":"Kondapalli","year":"2012","journal-title":"Open Biol."},{"issue":"7565","key":"10.1016\/j.bcp.2021.114588_b0080","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nature14879","article-title":"Mechanism of phospho-ubiquitin-induced PARKIN activation","volume":"524","author":"Wauer","year":"2015","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bcp.2021.114588_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004861","article-title":"Phosphorylation of mitochondrial polyubiquitin by PINK1 promotes Parkin mitochondrial tethering","volume":"10","author":"Shiba-Fukushima","year":"2014","journal-title":"PLoS Genet."},{"issue":"6","key":"10.1016\/j.bcp.2021.114588_b0090","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ncb2979","article-title":"Cargo recognition and trafficking in selective autophagy","volume":"16","author":"Stolz","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"7565","key":"10.1016\/j.bcp.2021.114588_b0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature14893","article-title":"The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy","volume":"524","author":"Lazarou","year":"2015","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bcp.2021.114588_b0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbabio.2016.12.008","article-title":"Dysregulation of mitophagy in carcinogenesis and tumor progression","volume":"1858","author":"Chang","year":"2017","journal-title":"Biochim. Biophys. Acta, Bioenerg."},{"issue":"1","key":"10.1016\/j.bcp.2021.114588_b0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.bcp.2021.114588_b0110","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/428839","article-title":"Nitazoxanide: A new thiazolide antiparasitic agent","volume":"40","author":"Fox","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.bcp.2021.114588_b0115","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4269\/ajtmh.1984.33.511","article-title":"Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections","volume":"33","author":"Rossignol","year":"1984","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.bcp.2021.114588_b0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2036.2003.01419.x","article-title":"Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru","volume":"17","author":"Favennec","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2021.114588_b0125","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1128\/AAC.44.9.2254-2258.2000","article-title":"In vitro and in vivo activities of nitazoxanide against Clostridium difficile","volume":"44","author":"McVay","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2021.114588_b0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: A first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antiviral Res."},{"issue":"11","key":"10.1016\/j.bcp.2021.114588_b0135","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1038\/s41388-019-1142-6","article-title":"Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain","volume":"39","author":"Ripani","year":"2020","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bcp.2021.114588_b0140","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1158\/1535-7163.MCT-12-1243","article-title":"A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide","volume":"12","author":"Fan-Minogue","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"10","key":"10.1016\/j.bcp.2021.114588_b0145","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41419-018-1058-z","article-title":"Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2021.114588_b0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mrfmmm.2014.05.005","article-title":"A functional perspective of nitazoxanide as a potential anticancer drug","volume":"768","author":"Di Santo","year":"2014","journal-title":"Mutat. Res."},{"issue":"6","key":"10.1016\/j.bcp.2021.114588_b0155","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-14-0792","article-title":"Three-dimensional cell culture-based screening identifies the anthelmintic drug nitazoxanide as a candidate for treatment of colorectal cancer","volume":"14","author":"Senkowski","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2021.114588_b0160","unstructured":"Qu Y, Olsen JR, Yuan X, Cheng PF, Levesque MP, Brokstad KA, Hoffman PS, Oyan AM, Zhang W, Kalland KH: Small molecule promotes \u03b2-catenin citrullination and inhibits Wnt signaling in cancer. Nature Chemical Biology."},{"issue":"10","key":"10.1016\/j.bcp.2021.114588_b0165","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/s41401-019-0220-1","article-title":"Nitazoxanide, an anti-parasitic drug, efficiently ameliorates learning and memory impairments in AD model mice","volume":"40","author":"Fan","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"04","key":"10.1016\/j.bcp.2021.114588_b0170","first-page":"86","article-title":"Jian, Lu, Yixiang, Xu, Jiaying, Wang, Xiaoxia, Qiu: Discovery of nitazoxanide-based derivatives as autophagy activators for the treatment of Alzheimer's disease","volume":"10","author":"Xiaokang","year":"2020","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.bcp.2021.114588_b0175","article-title":"Boosting bladder cancer treatment by intravesical nitazoxanide and bacillus calmette-gu\u00e9rin association","volume":"3","author":"Kiehl","year":"2020","journal-title":"World J. Urol."},{"key":"10.1016\/j.bcp.2021.114588_b0180","article-title":"The cycloartane triterpenoid ADCX impairs autophagic degradation through Akt overactivation and promotes apoptotic cell death in multidrug-resistant HepG2\/ADM cells","volume":"87","author":"Sun","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114588_b0185","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/361590","article-title":"The design of a quantitative western blot experiment","volume":"2014","author":"Taylor","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bcp.2021.114588_b0190","doi-asserted-by":"crossref","unstructured":"Zinchuk V, Zinchuk O: Quantitative colocalization analysis of confocal fluorescence microscopy images. Curr Protoc Cell Biol 2008, Chapter 4:Unit 4 19.","DOI":"10.1002\/0471143030.cb0419s39"},{"issue":"8","key":"10.1016\/j.bcp.2021.114588_b0195","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1158\/2159-8290.CD-13-0873","article-title":"PTEN-deficient tumors depend on AKT2 for maintenance and survival","volume":"4","author":"Chin","year":"2014","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.bcp.2021.114588_b0200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/adt.2014.573","article-title":"Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors","volume":"12","author":"Edmondson","year":"2014","journal-title":"Assay Drug Dev. Technol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114588_b0205","doi-asserted-by":"crossref","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","article-title":"Mitophagy and quality control mechanisms in mitochondrial maintenance","volume":"28","author":"Pickles","year":"2018","journal-title":"Curr. Biol."},{"issue":"8","key":"10.1016\/j.bcp.2021.114588_b0210","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/nprot.2017.060","article-title":"A fluorescence-based imaging method to measure in vitro and in vivo mitophagy using mt-Keima","volume":"12","author":"Sun","year":"2017","journal-title":"Nat. Protoc."},{"issue":"19","key":"10.1016\/j.bcp.2021.114588_b0215","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2571","article-title":"DQ-Red BSA trafficking assay in cultured cells to assess cargo delivery to lysosomes","volume":"7","author":"Marwaha","year":"2017","journal-title":"Bio Protocol"},{"issue":"3","key":"10.1016\/j.bcp.2021.114588_b0220","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030690","article-title":"Coleman MA et al.: Comparative Molecular Analysis of Cancer Behavior Cultured In Vitro, In Vivo, and Ex Vivo","volume":"12","author":"Hum","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.bcp.2021.114588_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002691","article-title":"Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis","volume":"8","author":"Lam","year":"2012","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.bcp.2021.114588_b0230","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00418-008-0394-y","article-title":"Lysosomes in iron metabolism, ageing and apoptosis","volume":"129","author":"Kurz","year":"2008","journal-title":"Histochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.bcp.2021.114588_b0235","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41556-018-0176-2","article-title":"Mechanisms of mitophagy in cellular homeostasis, physiology and pathology","volume":"20","author":"Palikaras","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bcp.2021.114588_b0240","article-title":"Atg8 family LC3\/GABARAP proteins are crucial for autophagosome-lysosome fusion but not autophagosome formation during PINK1\/Parkin mitophagy and starvation","author":"Thanh","year":"2016","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114588_b0245","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41419-019-1470-z","article-title":"Inhibition of PINK1\/Parkin-dependent mitophagy sensitizes multidrug-resistant cancer cells to B5G1, a new betulinic acid analog","volume":"10","author":"Yao","year":"2019","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bcp.2021.114588_b0250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1359-6446(04)03316-1","article-title":"Target-based drug discovery: is something wrong?","volume":"10","author":"Sams-Dodd","year":"2005","journal-title":"Drug Discovery Today"},{"issue":"4","key":"10.1016\/j.bcp.2021.114588_b0255","article-title":"Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer","volume":"33","author":"Yoshinori","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2021.114588_b0260","first-page":"203","article-title":"Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses","volume":"130","author":"Riedl","year":"2017","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.bcp.2021.114588_b0265","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-020-03736-4","article-title":"Synthetic antiprotozoal thiazolide drug induced apoptosis in colorectal cancer cells: Implications of IL-6\/JAK2\/STAT3 and p53\/caspases-dependent signaling pathways based on molecular docking and in vitro study","volume":"469","author":"Tantawy","year":"2020","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.bcp.2021.114588_b0270","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/med.21531","article-title":"The multifaceted role of autophagy in cancer and the microenvironment","volume":"39","author":"Folkerts","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bcp.2021.114588_b0275","article-title":"Hoffmann MJ et al.: Targeting urothelial carcinoma cells by combining cisplatin with a specific inhibitor of the autophagy-inducing class III PtdIns3K complex","volume":"36(4):160 e161\u2013160","author":"Schlutermann","year":"2018","journal-title":"Urol. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2021.114588_b0280","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000486222","article-title":"Chloroquine Enhances the Radiosensitivity of Bladder Cancer Cells by Inhibiting Autophagy and Activating Apoptosis","volume":"45","author":"Wang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2021.114588_b0285","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425247.2016.1100166","article-title":"Advances in intravesical therapy for urinary tract disorders","volume":"13","author":"Tyagi","year":"2016","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.bcp.2021.114588_b0290","doi-asserted-by":"crossref","unstructured":"Efficacy of intravesical therapies on the prevention of recurrence and progression of non\u2010muscle\u2010invasive bladder cancer: A systematic review and network meta\u2010analysis. Cancer Medicine 2020, 9(21).","DOI":"10.1002\/cam4.3513"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221001945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221001945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:10:30Z","timestamp":1762096230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221001945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":58,"alternative-id":["S0006295221001945"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114588","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitazoxanide impairs mitophagy flux through ROS-mediated mitophagy initiation and lysosomal dysfunction in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114588"}}